- Home
- NKTX vs FRD Comparison
NKTX vs FRD Comparison
Compare NKTX & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- FRD
- Stock Information
- Founded
- NKTX 2015
- FRD 1965
- Country
- NKTX United States
- FRD United States
- Employees
- NKTX N/A
- FRD N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- FRD Steel/Iron Ore
- Sector
- NKTX Health Care
- FRD Industrials
- Exchange
- NKTX Nasdaq
- FRD Nasdaq
- Market Cap
- NKTX 147.7M
- FRD 149.9M
- IPO Year
- NKTX 2020
- FRD N/A
- Fundamental
- Price
- NKTX $1.95
- FRD $21.62
- Analyst Decision
- NKTX Strong Buy
- FRD
- Analyst Count
- NKTX 5
- FRD 0
- Target Price
- NKTX $13.50
- FRD N/A
- AVG Volume (30 Days)
- NKTX 1.1M
- FRD 13.2K
- Earning Date
- NKTX 11-07-2025
- FRD 11-12-2025
- Dividend Yield
- NKTX N/A
- FRD 0.76%
- EPS Growth
- NKTX N/A
- FRD N/A
- EPS
- NKTX N/A
- FRD 1.21
- Revenue
- NKTX N/A
- FRD $464,826,000.00
- Revenue This Year
- NKTX N/A
- FRD N/A
- Revenue Next Year
- NKTX N/A
- FRD N/A
- P/E Ratio
- NKTX N/A
- FRD $17.36
- Revenue Growth
- NKTX N/A
- FRD N/A
- 52 Week Low
- NKTX $1.31
- FRD $12.24
- 52 Week High
- NKTX $3.81
- FRD $22.98
- Technical
- Relative Strength Index (RSI)
- NKTX 40.03
- FRD 54.60
- Support Level
- NKTX $1.85
- FRD $20.78
- Resistance Level
- NKTX $2.01
- FRD $21.70
- Average True Range (ATR)
- NKTX 0.13
- FRD 0.92
- MACD
- NKTX -0.04
- FRD 0.05
- Stochastic Oscillator
- NKTX 17.60
- FRD 57.27
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.